Results 111 to 120 of about 114,692 (269)
GLUCAGON ANTIBODIES AND AN IMMUNOASSAY FOR GLUCAGON* [PDF]
, 1961 Roger H. Unger +3 more
openalex +3 more sources
Drug Testing and Analysis, EarlyView.Scenarios of drug exposure and administration as well as detection assays for drugs and methods of sports doping published between 2023 and 2024 are critically reviewed and evaluated in context with the Prohibited List 2024 as established by the World Anti‐Doping Agency.
Mario Thevis +2 more
wiley +1 more source
The Glucagon Content of Crystalline Insulin Preparations [PDF]
, 1954 Alfred Staub, Otto K. Behrens
openalex +1 more source
ESC Heart Failure, EarlyView.Abstract Aims Sodium–glucose co‐transporter‐2 (SGLT2) inhibitors improve health status and outcomes in the setting of heart failure (HF) across the range of ejection fraction (EF). Baseline kidney disease is common in HF, complicates HF management and is strongly linked to worse health status. This study aimed to assess whether the treatment effects of
Andrew P. Ambrosy +12 more
wiley +1 more source
THE INTERACTION OF GLUCAGON AND INSULIN ON BLOOD GLUCOSE [PDF]
, 1956 Harold Elrick +3 more
openalex +1 more source
ESC Heart Failure, EarlyView.Abstract Heart failure with preserved ejection fraction (HFpEF) is defined by heart failure (HF) with a left ventricular ejection fraction (LVEF) of at least 50%. HFpEF has a complex and heterogeneous pathophysiology with multiple co‐morbidities contributing to its presentation. Establishing the diagnosis of HFpEF can be challenging.
Roy Rasalam +4 more
wiley +1 more source
Effect of Glucagon on Gastric Secretion in the Dog [PDF]
, 1960 Sonya Clarke +2 more
openalex +1 more source
Assessing the link of malnutrition with diabetes and mortality risk in heart failure patients
ESC Heart Failure, EarlyView.Abstract Aims Malnutrition is increasingly recognized as a significant factor influencing the clinical outcomes of patients with heart failure (HF). Diabetes exacerbates risks like hospitalizations and mortality due to cardiovascular complications. The aim of this study was to explore the association of malnutrition with diabetes and its prognostic ...
Konstantinos Prokopidis +8 more
wiley +1 more source
Comparing the effects of intravenous injection and intranasal atomisation of detomidine in sheep
Veterinary Medicine and Science, Volume 9, Issue 1, Page 353-362, January 2023., 2023 This paper compares the intravenous and intranasal routs of Detomidine administration in sheep. Abstract Background Detomidine is an α‐2 agonist sedative drug which reduces the release of norepinephrine in nerves. Administering this drug through intranasal (IN) route could cause direct transmission to the central nervous system.
Touran Tahmasbi +3 more
wiley +1 more source
Basal Plasma Glucagon Levels of Man* [PDF]
, 1967 Joseph E. Sokal, Ediz Z. Ezdinli
openalex +1 more source